751611118	751611118	CD	B-NP	O
|	|	NN	I-NP	O
TH	TH	NN	I-NP	O
|	|	NN	I-NP	O
51425337	51425337	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
7578412	7578412	CD	B-NP	O
|	|	CC	I-NP	O
1/16/2007	1/16/2007	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/25/2007	10/25/2007	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/7/2007	10/7/2007	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
Tall	Tall	NNP	O	O
A	A	DT	B-NP	O
Bichoca	Bichoca	NNP	I-NP	O
416-43-23-8	416-43-23-8	CD	I-NP	O
Valetul	Valetul	NNP	I-NP	O
In	In	IN	B-PP	O
Broke	Broke	NNP	B-NP	O
Go	Go	NNP	I-NP	O
O	O	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
11/19/07	11/19/07	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
OPLINGER	OPLINGER	NNP	B-NP	O
,	,	,	O	O
SHANE	SHANE	NNP	B-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
services	service	NNS	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	O
ACID	ACID	NN	I-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
2	2	CD	I-NP	O
.	.	.	O	O

ALLOPURINOL	ALLOPURINOL	NN	B-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QOD	QOD	NN	I-NP	B-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

AMIODARONE	AMIODARONE	NN	B-NP	B-protein
200	200	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

ATORVASTATIN	ATORVASTATIN	NN	B-NP	O
80	80	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

CLOPIDOGREL	CLOPIDOGREL	NN	B-NP	O
75	75	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

DOCUSATE	DOCUSATE	JJ	B-NP	O
SODIUM	SODIUM	NN	I-NP	O
100	100	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

DOXAZOSIN	DOXAZOSIN	NN	B-NP	O
2	2	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
8	8	CD	I-NP	O
.	.	.	O	O

ESOMEPRAZOLE	ESOMEPRAZOLE	RB	B-NP	O
40	40	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	B-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

FERROUS	FERROUS	DT	B-NP	O
SULFATE	SULFATE	JJ	I-NP	O
325	325	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
QD	QD	NN	I-NP	O
10	10	CD	I-NP	O
.	.	.	O	O

FUROSEMIDE	FUROSEMIDE	RB	B-NP	O
20	20	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

GEMFIBROZIL	GEMFIBROZIL	NN	B-NP	O
300	300	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

HYDRALAZINE	HYDRALAZINE	NN	B-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	O
13	13	CD	I-NP	O
.	.	.	O	O

ISOSORBIDE	ISOSORBIDE	NNP	B-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR	SR	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
120	120	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

LORAZEPAM	LORAZEPAM	NN	B-NP	O
0.5	0.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
15	15	CD	I-NP	O
.	.	.	O	O

METHADONE	METHADONE	NN	B-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

METOPROLOL	METOPROLOL	NNP	B-NP	O
SUCCINATE	SUCCINATE	NNP	I-NP	O
EXTENDED	EXTENDED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

WARFARIN	WARFARIN	NNP	B-NP	O
SODIUM	SODIUM	NNP	I-NP	O
1.5	1.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
MEDICATIONS	MEDICATIONS	NNP	I-NP	O
ON	ON	NNP	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NN	B-NP	B-protein
100	100	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
EVERY	EVERY	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DAY	DAY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/10/07	5/10/07	CD	B-NP	O
by	by	IN	B-PP	O
BOUTOT	BOUTOT	NNP	B-NP	O
,	,	,	O	O
DALTON	DALTON	NNP	B-NP	O
J	J	NNP	I-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
731732962	731732962	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
AMIODARONE	AMIODARONE	NN	I-NP	O
200	200	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
April	April	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/10/07	5/10/07	CD	B-NP	O
by	by	IN	B-PP	O
WALVOORD	WALVOORD	NNP	B-NP	O
,	,	,	O	O
RUSSELL	RUSSELL	NNP	B-NP	O
E	E	NNP	I-NP	O
A.	A.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
731732962	731732962	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/10/07	5/10/07	CD	B-NP	O
by	by	IN	B-PP	O
GOLLOGLY	GOLLOGLY	NNP	B-NP	O
,	,	,	O	O
JOHNNY	JOHNNY	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
AMIODARONE	AMIODARONE	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
ECASA	ECASA	NNP	B-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/10/07	5/10/07	CD	B-NP	O
by	by	IN	B-PP	O
JURAN	JURAN	NNP	B-NP	O
,	,	,	O	O
KIP	KIP	NNP	B-NP	O
M	M	NNP	I-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
731732962	731732962	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/10/07	5/10/07	CD	B-NP	O
by	by	IN	B-PP	O
GLUNT	GLUNT	NNP	B-NP	O
,	,	,	O	O
LUCIANO	LUCIANO	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
ECASA	ECASA	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
QD	QD	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	O
047958748	047958748	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
NSAIDs	NSAID	NNS	B-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
tolerates	tolerate	VBZ	B-VP	O
LIPITOR	LIPITOR	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
80	80	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/10/07	5/10/07	CD	B-NP	O
by	by	IN	B-PP	O
SCHON	SCHON	NNP	B-NP	O
,	,	,	O	O
AL	AL	NNP	B-NP	O
B	B	NNP	I-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
731732962	731732962	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/10/07	5/10/07	CD	B-NP	O
by	by	IN	B-PP	O
ROSSO	ROSSO	NN	B-NP	B-protein
,	,	,	O	O
WARD	WARD	NNP	B-NP	O
H.	H.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	B-NP	O
PO	PO	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
663112361	663112361	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Previous	Previous	JJ	B-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/10/07	5/10/07	CD	B-NP	O
by	by	IN	B-PP	O
CASSEL	CASSEL	NNP	B-NP	O
,	,	,	O	O
KEVEN	KEVEN	NNP	B-NP	O
I.	I.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
AMIODARONE	AMIODARONE	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
205674826	205674826	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
AMIODARONE	AMIODARONE	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
CLOPIDOGREL	CLOPIDOGREL	NN	B-NP	B-protein
75	75	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
November	November	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/10/07	5/10/07	CD	B-NP	O
by	by	IN	B-PP	O
AULER	AULER	NNP	B-NP	O
,	,	,	O	O
KEENAN	KEENAN	NNP	B-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
CLOPIDOGREL	CLOPIDOGREL	NN	B-NP	O
PO	PO	NN	I-NP	O
75	75	CD	I-NP	O
MG	MG	NN	I-NP	O
QD	QD	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
753242426	753242426	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
Pt	Pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	O	O
a	a	DT	B-NP	O
POSSIBLE	POSSIBLE	NN	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
TICLOPIDINE	TICLOPIDINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
;	;	:	O	O
reaction	reaction	NN	B-NP	O
is	be	VBZ	B-VP	O
Unknown	Unknown	JJ	B-ADJP	O
.	.	.	O	O

Reason	Reason	NN	B-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
pt	pt	NN	B-NP	O
tolerates	tolerate	VBZ	B-VP	O
COLACE	COLACE	NN	B-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
DOCUSATE	DOCUSATE	NNP	I-NP	I-protein
SODIUM	SODIUM	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
100	100	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
DOXAZOSIN	DOXAZOSIN	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QPM	QPM	NNP	I-NP	I-protein
Starting	Starting	NNP	I-NP	I-protein
Today	Today	NNP	I-NP	I-protein
April	April	NNP	I-NP	I-protein
HOLD	HOLD	NNP	I-NP	I-protein
IF	IF	NNP	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	B-protein
<	<	SYM	O	I-protein
100	100	CD	B-NP	I-protein
NEXIUM	NEXIUM	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	I-protein
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
40	40	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
FERROUS	FERROUS	NNP	I-NP	I-protein
SULFATE	SULFATE	NNP	I-NP	I-protein
325	325	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
Food/Drug	Food/Drug	NNP	I-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Avoid	Avoid	NNP	I-NP	I-protein
milk	milk	NN	I-NP	I-protein
and	and	CC	I-NP	O
antacid	antacid	NN	I-NP	O
LASIX	LASIX	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
FUROSEMIDE	FUROSEMIDE	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
20	20	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
95	95	CD	B-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
300	300	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
5/10/07	5/10/07	CD	B-NP	O
by	by	IN	B-PP	O
MAKHIJA	MAKHIJA	NNP	B-NP	O
,	,	,	O	O
JERMAINE	JERMAINE	NNP	B-NP	O
P	P	NNP	I-NP	O
E.	E.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
731732962	731732962	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
GEMFIBROZIL	GEMFIBROZIL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/10/07	5/10/07	CD	B-NP	O
by	by	IN	B-PP	O
WECHSELBLATT	WECHSELBLATT	NNP	B-NP	O
,	,	,	O	O
DEMARCUS	DEMARCUS	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
GEMFIBROZIL	GEMFIBROZIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
HYDRALAZINE	HYDRALAZINE	NN	B-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
25	25	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Take	Take	VB	B-VP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

IMDUR	IMDUR	NN	B-NP	O
ER	ER	NN	I-NP	B-protein
-LRB-	-LRB-	HYPH	B-NP	O
ISOSORBIDE	ISOSORBIDE	NN	I-NP	B-protein
MONONITRATE	MONONITRATE	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
SR	SR	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
-RRB-	-RRB-	HYPH	B-NP	O
120	120	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
BID	BID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
100	100	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Give	Give	NN	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
ATIVAN	ATIVAN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
LORAZEPAM	LORAZEPAM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
1	1	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
April	April	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Anxiety	Anxiety	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
sedated	sedate	VBN	B-VP	O
or	or	CC	O	O
rr	rr	NN	B-NP	B-protein
<	<	SYM	O	I-protein
12	12	CD	B-NP	I-protein
METHADONE	METHADONE	NN	I-NP	I-protein
20	20	CD	B-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sedated	sedate	VBN	B-VP	O
or	or	CC	O	O
RR	RR	NN	B-NP	B-protein
<	<	SYM	O	I-protein
12	12	CD	B-NP	I-protein
LOPRESSOR	LOPRESSOR	NNP	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
April	April	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
HR	HR	NN	B-NP	B-protein
<	<	SYM	B-ADJP	I-protein
50	50	CD	B-NP	I-protein
,	,	,	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
NITROGLYCERIN	NITROGLYCERIN	NN	I-NP	O
1/150	1/150	CD	B-NP	O
-LRB-	-LRB-	HYPH	I-NP	O
0.4	0.4	CD	I-NP	O
MG	MG	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
TAB	TAB	NN	I-NP	O
SL	SL	NN	I-NP	O
q5min	q5min	NN	I-NP	O
x	x	SYM	B-NP	O
3	3	CD	I-NP	O
PRN	PRN	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	I-protein
100	100	CD	B-NP	I-protein
COUMADIN	COUMADIN	NN	I-NP	I-protein
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
ROUTINE	ROUTINE	NNP	I-NP	O
,	,	,	O	O
20	20	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Standard	Standard	NNP	I-NP	O
Admin	Admin	NNP	I-NP	O
Time	Time	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
5/10/07	5/10/07	CD	B-NP	O
by	by	IN	B-PP	O
GLAVIANO	GLAVIANO	NNP	B-NP	O
,	,	,	O	O
CORNELL	CORNELL	NNP	B-NP	O
A	A	NNP	I-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ATORVASTATIN	ATORVASTATIN	NNP	B-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ALLOPURINOL	ALLOPURINOL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AMIODARONE	AMIODARONE	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
GEMFIBROZIL	GEMFIBROZIL	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Walking	Walk	VBG	B-VP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Fabian	Fabian	NNP	I-NP	O
Puotinen	Puotinen	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Sun	Sun	NNP	I-NP	O
Alegarlbrokeny	Alegarlbrokeny	NNP	I-NP	O
Co	Co	NNP	I-NP	O
BTBMH	BTBMH	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
within	within	IN	B-PP	O
one	one	CD	B-NP	O
wk	wk	NN	I-NP	O
;	;	:	O	O
Dr.	Dr.	NNP	B-NP	O
Manual	Manual	NNP	I-NP	O
office	office	NN	I-NP	O
will	will	MD	B-VP	O
call	call	VB	I-VP	O
you	you	PRP	B-NP	O
with	with	IN	B-PP	O
appointment	appointment	NN	B-NP	O
dat/time	dat/time	NN	I-NP	O
;	;	:	O	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
do	do	VBP	B-VP	O
not	not	RB	I-VP	O
hear	hear	VB	I-VP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
office	office	NN	I-NP	O
in	in	IN	B-PP	O
one	one	CD	B-NP	O
day	day	NN	I-NP	O
,	,	,	O	O
then	then	RB	O	O
call	call	VB	B-VP	O
979-172-1132	979-172-1132	CD	B-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
an	an	DT	B-NP	O
appointment	appointment	NN	I-NP	O
,	,	,	O	O
Arrange	Arrange	NNP	B-NP	O
INR	INR	NNP	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
on	on	IN	B-PP	O
6/28/07	6/28/07	CD	B-NP	O
with	with	IN	B-PP	O
f/u	f/u	NN	B-NP	O
INR	INR	NNP	B-NP	O
's	's	POS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
drawn	draw	VBN	I-VP	O
every	every	DT	B-NP	O
3	3	CD	I-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
's	's	POS	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
VNA	VNA	NN	B-NP	B-protein
/	/	SYM	O	O
CMC	CMC	NN	B-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
ALLERGY	ALLERGY	NN	I-NP	O
:	:	:	O	O
NSAIDs	NSAID	NNS	B-NP	O
,	,	,	O	O
TICLOPIDINE	TICLOPIDINE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
,	,	,	O	O
HYDROMORPHONE	HYDROMORPHONE	NN	B-NP	O
HCL	HCL	NN	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NN	B-NP	O
for	for	IN	B-PP	O
Causing	Cause	VBG	B-VP	O
Admission	Admission	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
hypertension	hypertension	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
CAD	CAD	NNP	I-NP	O
,	,	,	O	O
S/P	S/P	NNP	B-NP	O
CABG	CABG	NNP	I-NP	O
S/P	S/P	NN	I-NP	O
PTCA	PTCA	NN	I-NP	O
GOUT	GOUT	NN	I-NP	O
PROTEINURIA	PROTEINURIA	NN	I-NP	O
CRI	CRI	NN	I-NP	O
hypertriglyceridemia	hypertriglyceridemia	NN	I-NP	O
htn	htn	NN	I-NP	O
asymmetric	asymmetric	JJ	I-NP	O
BP	BP	NN	I-NP	O
afib	afib	NN	I-NP	O
s/p	s/p	NN	I-NP	O
PM	PM	NNP	I-NP	O
GERD	GERD	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
gastroesophageal	gastroesophageal	JJ	I-NP	O
reflux	reflux	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
NIDDM	NIDDM	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
pancytopenia	pancytopenia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
pancytopenia	pancytopenia	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
neuropathy	neuropathy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
hepatitis	hepatitis	NN	I-NP	O
B	B	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
hepatitis	hepatitis	NN	I-NP	O
B	B	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
BPH	BPH	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
benign	benign	JJ	I-NP	O
prostatic	prostatic	JJ	I-NP	O
hypertrophy	hypertrophy	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
None	None	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
titrated	titrate	VBN	B-NP	O
bp	bp	NN	I-NP	O
meds	med	VBZ	B-VP	O
BRIEF	BRIEF	NN	B-NP	B-protein
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
CP	CP	NN	B-NP	B-DNA
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
***	***	SYM	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
Pt	Pt	NN	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
60yo	60yo	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	O	O
1988	1988	CD	B-NP	O
LIMA	LIMA	NN	I-NP	O
to	to	TO	B-PP	O
LAD	LAD	NN	B-NP	O
and	and	CC	I-NP	O
RIMA	RIMA	NN	I-NP	B-protein
to	to	TO	B-PP	O
RCA	RCA	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
and	and	CC	O	O
stent	stent	NN	B-NP	O
to	to	TO	B-PP	O
OM	OM	NN	B-NP	B-DNA
9/21	9/21	CD	I-NP	I-DNA
.	.	.	O	O

Cath	Cath	NN	B-NP	O
11/29	11/29	CD	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
native	native	JJ	I-NP	O
LAD	LAD	NN	I-NP	O
dz	dz	NN	I-NP	O
,	,	,	O	O
patent	patent	NN	B-NP	O
LIMA	LIMA	NNP	I-NP	O
,	,	,	O	O
occluded	occlude	VBD	B-VP	O
RIMA	RIMA	NN	B-NP	O
and	and	CC	I-NP	O
RCA	RCA	NN	I-NP	B-protein
with	with	IN	B-PP	O
L	L	NN	B-NP	O
to	to	TO	B-PP	O
R	R	NN	B-NP	O
collaterals	collateral	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
h/o	h/o	NN	I-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
afib	afib	NN	B-NP	O
,	,	,	O	O
mobitz	mobitz	NN	B-NP	O
II	II	CD	I-NP	O
heart	heart	NN	I-NP	O
block	block	NN	I-NP	O
s/p	s/p	NN	I-NP	O
PM	PM	NN	I-NP	O
11/29	11/29	CD	I-NP	O
,	,	,	O	O
CRI	CRI	NNP	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
frequent	frequent	JJ	B-NP	O
CP	CP	NN	I-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
``	``	``	O	O
punching/choking	punching/choke	VBG	B-VP	O
sensation	sensation	NN	B-NP	O
''	''	''	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
multiple	multiple	JJ	B-NP	O
hospital	hospital	NN	I-NP	O
admissions	admission	NNS	I-NP	O
-LRB-	-LRB-	-LRB	O	B-protein
most	most	RBS	B-ADJP	O
recent	recent	JJ	I-ADJP	O
8/29/21	8/29/21	CD	B-NP	O
on	on	IN	B-PP	O
cards	card	NNS	B-NP	B-protein
service	service	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

Pt	Pt	NN	B-NP	O
recently	recently	RB	B-VP	O
told	tell	VBN	I-VP	O
by	by	IN	B-PP	O
cards	card	NNS	B-NP	O
to	to	TO	B-VP	O
stop	stop	VB	I-VP	O
hydral	hydral	JJ	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
took	take	VBD	B-VP	O
1/2	1/2	CD	B-NP	O
dose	dose	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/10	10/10	CD	B-NP	O
am	am	NN	I-NP	O
noted	note	VBD	B-VP	O
SBP	SBP	NN	B-NP	B-protein
190	190	CD	I-NP	I-protein
.	.	.	O	O

Developed	Develop	VBN	B-VP	O
punching/choking	punching/choke	VBG	B-VP	O
CP	CP	NN	B-NP	B-protein
w	w	NN	I-NP	I-protein
/	/	SYM	B-NP	O
mild	mild	JJ	I-NP	O
dizziness	dizziness	NN	I-NP	O
and	and	CC	I-NP	O
SOB	SOB	NN	I-NP	B-protein
.	.	.	O	O

Sx	Sx	NN	B-NP	O
lasted	last	VBD	B-VP	O
few	few	JJ	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

EMS	EMS	NNS	B-NP	O
called	call	VBN	B-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
given	give	VBN	I-NP	O
ASA	ASA	NN	I-NP	O
and	and	CC	I-NP	O
nitro	nitro	NN	I-NP	O
spray	spray	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
ED	ED	VBN	B-NP	B-cell_line
HR	HR	NN	I-NP	I-cell_line
90s	90	NNS	I-NP	I-cell_line
,	,	,	O	O
SBP	SBP	NN	B-NP	O
170s	170	NNS	I-NP	O
.	.	.	O	O

Markers	Marker	NNS	B-NP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

Rx	Rx	NN	B-NP	B-protein
`	`	``	O	O
ed	ed	VBN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	O	O
morphine	morphine	NN	B-NP	O
,	,	,	O	O
nitro	nitro	NN	B-NP	O
,	,	,	O	O
lopressor	lopressor	NN	B-NP	O
.	.	.	O	O

CP	CP	NN	B-NP	B-DNA
stuttered	stutter	VBD	B-VP	O
,	,	,	O	O
then	then	RB	B-VP	O
resolved	resolve	VBN	I-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
admitted	admit	VBD	B-VP	O
to	to	TO	B-PP	O
GMS	GMS	NNP	B-NP	O
for	for	IN	B-PP	O
further	further	JJ	B-NP	O
mgt	mgt	NN	I-NP	O
.	.	.	O	O

***	***	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
see	see	VB	B-VP	O
PMHx	PMHx	NN	B-NP	B-protein
***	***	SYM	B-NP	O
HOME	HOME	NN	I-NP	O
MEDS	MEDS	NN	I-NP	O
:	:	:	O	O
methadone	methadone	NN	B-NP	O
20	20	CD	I-NP	O
bid	bid	NN	B-VP	O
,	,	,	O	O
ativan	ativan	NN	B-NP	O
0.5	0.5	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
asa	asa	NN	B-NP	O
325	325	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
75	75	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
80	80	CD	I-NP	O
qhs	qh	NNS	I-NP	O
,	,	,	O	O
gemfibrozil	gemfibrozil	NN	B-NP	O
300	300	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
amio	amio	NN	B-NP	O
200	200	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
to	to	TO	B-PP	O
XL	XL	NN	B-NP	O
25	25	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
imdur	imdur	IN	B-ADVP	O
120	120	CD	B-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
hydral	hydral	JJ	B-ADJP	O
taking	take	VBG	B-VP	O
25	25	CD	B-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
lasix	lasix	CD	B-NP	O
20	20	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
colace	colace	NN	B-NP	O
,	,	,	O	O
iron	iron	NN	B-NP	O
,	,	,	O	O
nexium	nexium	NN	B-NP	O
40	40	CD	I-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
doxazosin	doxazosin	NN	B-NP	O
2	2	CD	I-NP	O
qd	qd	NN	I-NP	O
,	,	,	O	O
allopurinol	allopurinol	NN	B-NP	O
100	100	CD	I-NP	O
qod	qod	NN	I-NP	O
,	,	,	O	O
***	***	SYM	B-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
NSAIDS	NSAIDS	NN	B-NP	O
,	,	,	O	O
ticlopidin	ticlopidin	NN	B-NP	O
***	***	SYM	O	O
Admit	Admit	NNP	B-NP	O
PE	PE	NNP	I-NP	O
:	:	:	O	O
97.5	97.5	CD	B-NP	O
69	69	CD	I-NP	O
140s/70s	140s/70s	CD	I-NP	O
L	L	NN	I-NP	B-protein
116/66	116/66	CD	B-NP	I-protein
R	R	NN	I-NP	I-protein
sat	sit	VBD	B-VP	O
98	98	CD	B-NP	O
%	%	NN	I-NP	O
2L	2L	NN	I-NP	O
NAD	NAD	NN	I-NP	O
,	,	,	O	O
AXOX3	AXOX3	NN	B-NP	B-protein
CV	CV	NN	I-NP	O
:	:	:	O	O
JVP	JVP	NN	B-NP	B-protein
7	7	CD	I-NP	I-protein
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
2/6	2/6	CD	I-NP	I-protein
SEN	SEN	NNP	I-NP	I-protein
@	@	NNP	I-NP	I-protein
LSB	LSB	NNP	I-NP	I-protein
Pulm	Pulm	NNP	I-NP	O
:	:	:	O	O
CTAB	CTAB	NN	B-NP	B-protein
Abd	Abd	NN	I-NP	O
:	:	:	O	O
benign	benign	JJ	B-NP	O
Ext	Ext	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
edema	edema	NN	I-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
DP	DP	NN	I-NP	O
neuro	neuro	NN	I-NP	O
:	:	:	O	O
nonfocal	nonfocal	JJ	B-NP	O
***	***	SYM	I-NP	O
ADMIT	ADMIT	NN	I-NP	O
LABS	LABS	NN	I-NP	O
:	:	:	O	O
Wbc	Wbc	NN	B-NP	B-protein
3	3	CD	I-NP	I-protein
hct	hct	NN	I-NP	I-protein
31	31	CD	B-NP	I-protein
plt	plt	NN	I-NP	I-protein
119	119	CD	B-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
pancyto	pancyto	NN	I-NP	I-protein
old	old	JJ	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	O	O
co2	co2	NN	B-NP	O
19	19	CD	I-NP	O
,	,	,	O	O
lytes	lyte	NNS	B-NP	O
ok	ok	VBP	B-VP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.9	1.9	CD	I-NP	I-protein
,	,	,	O	O
biomarkers	biomarker	NNS	B-NP	O
neg	neg	NN	I-NP	O
x	x	SYM	B-NP	O
2	2	CD	I-NP	O
***	***	SYM	I-NP	O
STUDIES	STUDIES	NN	I-NP	O
:	:	:	O	O
EKG	EKG	NN	B-NP	O
:	:	:	O	O
a-paced	a-paced	JJ	B-ADJP	O
,	,	,	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
ischemic	ischemic	JJ	I-NP	O
changes	change	NNS	I-NP	O
10/10	10/10	CD	B-NP	O
CXR	CXR	NN	I-NP	B-protein
:	:	:	O	O
stable	stable	JJ	B-NP	O
,	,	,	I-NP	O
mild	mild	JJ	I-NP	O
cardiomegaly	cardiomegaly	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
process	process	NN	I-NP	O
8/19	8/19	CD	I-NP	O
Echo	Echo	NNP	I-NP	O
:	:	:	O	O
60	60	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
significant	significant	JJ	I-NP	O
change	change	NN	I-NP	O
from	from	IN	B-PP	O
prior	prior	JJ	B-NP	O
study	study	NN	I-NP	O
10/21/15	10/21/15	CD	B-NP	O
PFTs	PFT	NNS	I-NP	O
:	:	:	O	O
wnl	wnl	NN	B-NP	O
.	.	.	O	O

***	***	SYM	B-NP	O
CONSULTS	CONSULTS	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
***	***	SYM	B-NP	O
EVENTS	EVENTS	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
***	***	SYM	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
BY	BY	NN	I-NP	O
SYSTEM	SYSTEM	NN	I-NP	O
1	1	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
CV	CV	NN	I-NP	O
:	:	:	O	O
Patiet	Patiet	NN	B-NP	O
with	with	IN	B-PP	O
CAD	CAD	NN	B-NP	B-protein
s/p	s/p	NN	I-NP	I-protein
CABG	CABG	NN	I-NP	I-protein
,	,	,	O	O
stents	stent	NNS	B-NP	O
,	,	,	O	O
recurrent	recurrent	JJ	B-NP	O
CP	CP	NN	I-NP	B-DNA
.	.	.	O	O

On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
CP	CP	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
in	in	IN	B-PP	O
setting	setting	NN	B-NP	O
of	of	IN	B-PP	O
HTN	HTN	NN	B-NP	B-protein
to	to	TO	B-PP	O
190s	190s	CD	B-NP	O
.	.	.	O	O

It	It	PRP	B-NP	O
occured	occur	VBD	B-VP	O
likely	likely	RB	B-ADJP	O
secondary	secondary	JJ	I-ADJP	O
to	to	TO	B-VP	O
strain	strain	VB	I-VP	O
from	from	IN	B-PP	O
hypertesnion	hypertesnion	NN	B-NP	O
.	.	.	O	O

EKG	EKG	NN	B-NP	B-protein
remained	remain	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	B-protein
had	have	VBD	B-VP	I-protein
neg	neg	NN	B-NP	I-protein
biomarkers	biomarker	NNS	I-NP	I-protein
x	x	SYM	B-NP	I-protein
3	3	CD	I-NP	I-protein
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	O
,	,	,	O	O
nitrates	nitrate	NNS	B-NP	O
,	,	,	O	O
lopressor	lopressor	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
increased	increase	VBD	B-VP	O
-RRB-	-RRB-	NN	B-NP	B-protein
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
gemfibrozil	gemfibrozil	NN	B-NP	O
,	,	,	O	O
hydralazine	hydralazine	NN	B-NP	O
.	.	.	O	O

Presumably	Presumably	RB	B-ADVP	O
not	not	RB	I-ADVP	O
on	on	IN	B-PP	O
acei	acei	NN	B-NP	O
2/2	2/2	CD	I-NP	O
severe	severe	JJ	I-NP	O
CRI	CRI	NN	I-NP	O
.	.	.	O	O

Of	Of	IN	B-PP	O
note	note	NN	B-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
h/o	h/o	NN	B-NP	O
assymetric	assymetric	JJ	I-NP	O
BP	BP	NN	I-NP	O
b/w	b/w	NN	I-NP	O
2	2	CD	B-NP	O
arms	arm	NNS	I-NP	O
.	.	.	O	O

ON	ON	NN	B-NP	O
discharge	discharge	VBP	B-VP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
BP	BP	NN	I-NP	O
was	be	VBD	B-VP	O
120-164/77	120-164/77	CD	B-NP	O
-87	-87	CD	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
was	be	VBD	B-VP	O
euvolemic	euvolemic	JJ	B-ADJP	O
with	with	IN	B-PP	O
stable	stable	JJ	B-NP	O
weight	weight	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
74.8	74.8	CD	I-NP	O
kg	kg	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
from	from	IN	B-PP	O
discharge	discharge	NN	B-NP	O
so	so	RB	B-ADVP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
home	home	NN	B-NP	O
lasix	lasix	NN	I-NP	O
.	.	.	O	O

Patient	Patient	NN	B-NP	O
had	have	VBD	B-VP	O
rate	rate	NN	B-NP	O
controlled	controlled	JJ	I-NP	O
afib	afib	NN	I-NP	O
with	with	IN	B-PP	O
PM	PM	NN	B-NP	O
in	in	IN	B-PP	O
place	place	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
continued	continued	JJ	B-NP	O
lopressor	lopressor	NN	I-NP	O
,	,	,	O	O
amio	amio	NN	B-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
NEURO	NEURO	NN	I-NP	O
:	:	:	O	O
For	For	IN	B-PP	O
neuropathy	neuropathy	NN	B-NP	O
,	,	,	O	O
continued	continue	VBD	B-VP	O
home	home	NN	B-NP	O
methadone	methadone	NN	I-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
PSYCH	PSYCH	NN	I-NP	O
:	:	:	O	O
For	For	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
,	,	,	O	O
continued	continue	VBD	B-VP	O
ativan	ativan	NN	B-NP	O
PRN	PRN	NN	I-NP	O
at	at	IN	B-PP	O
1mg	1mg	NN	B-NP	O
dose	dose	NN	I-NP	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
psychiatric	psychiatric	JJ	B-NP	O
evaluation	evaluation	NN	I-NP	O
for	for	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
PULM	PULM	NN	I-NP	O
:	:	:	O	O
Satting	Satte	VBG	B-VP	O
well	well	RB	B-ADVP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
.	.	.	O	O

PFTs	PFT	NNS	B-NP	O
ok	ok	VBP	B-VP	O
on	on	IN	B-PP	O
amio	amio	NN	B-NP	O
.	.	.	O	O

5	5	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
RENAL	RENAL	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
CRI	CRI	NN	I-NP	O
*	*	SYM	B-NP	O
Cr	Cr	NN	I-NP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

Renally	Renally	RB	B-NP	O
dose	dose	NN	I-NP	O
new	new	JJ	I-NP	O
meds	med	NNS	I-NP	O
+	+	SYM	B-NP	O
replete	replete	JJ	B-NP	O
lytes	lyte	NNS	I-NP	O
6	6	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
GI	GI	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
hep	hep	NN	I-NP	O
B	B	NN	I-NP	O
*	*	SYM	B-NP	O
LFTs	LFT	NNS	I-NP	O
wnl	wnl	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
HEME	HEME	NN	I-NP	B-protein
:	:	:	O	O
*	*	SYM	B-NP	O
pancytopenia	pancytopenia	NN	I-NP	O
*	*	SYM	B-VP	O
Stable	Stable	JJ	B-ADJP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
seen	see	VBN	B-VP	O
by	by	IN	B-PP	O
heme	heme	NN	B-NP	B-protein
,	,	,	O	O
but	but	CC	O	O
is	be	VBZ	B-VP	O
refusing	refuse	VBG	I-VP	O
bone	bone	NN	B-NP	O
marrow	marrow	NN	I-NP	O
bx	bx	NN	I-NP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
iron	iron	NN	I-NP	O
replacement	replacement	NN	I-NP	O
.	.	.	O	O

Continued	Continue	VBN	B-NP	O
coumadin	coumadin	NN	I-NP	O
at	at	IN	B-PP	O
2mg	2mg	NN	B-NP	O
qhs	qh	NNS	I-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	B-protein
on	on	IN	B-PP	O
discharge	discharge	NN	B-NP	O
was	be	VBD	B-VP	O
1.8	1.8	CD	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Goal	Goal	NNP	I-NP	O
2-3	2-3	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
-RRB-	-RRB-	JJ	I-NP	O
ENDO	ENDO	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
NIDDM	NIDDM	NN	I-NP	O
*	*	SYM	B-NP	O
Diet	Diet	NN	I-NP	O
controlled	control	VBN	B-VP	O
.	.	.	O	O

SSI	SSI	NN	B-NP	O
9	9	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
RHEUM	RHEUM	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
gout	gout	NN	I-NP	O
*	*	SYM	B-NP	O
No	No	DT	B-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

Continue	Continue	IN	B-PP	O
renally	renally	RB	B-NP	O
dosed	dose	VBN	I-NP	O
allopurinol	allopurinol	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
GU	GU	NN	I-NP	O
:	:	:	O	O
*	*	SYM	B-NP	O
BPH	BPH	NN	I-NP	O
*	*	SYM	B-NP	O
Continue	Continue	NN	I-NP	O
doxazosin	doxazosin	NN	I-NP	O
.	.	.	O	O

FEN	FEN	NN	B-NP	O
:	:	:	O	O
cardiac	cardiac	JJ	B-NP	O
,	,	,	I-NP	O
diabetic	diabetic	JJ	I-NP	O
diet	diet	NN	I-NP	O
PROPH	PROPH	NN	I-NP	O
:	:	:	O	O
PPI	PPI	NN	B-NP	B-protein
/	/	SYM	B-NP	O
coumadin	coumadin	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
if	if	IN	B-SBAR	O
ROMI	ROMI	NN	B-NP	O
neg	neg	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
***	***	SYM	B-NP	O
CODE	CODE	NN	I-NP	O
:	:	:	O	O
FULL	FULL	NN	B-NP	O
***	***	SYM	B-NP	O
CONTACTS	CONTACTS	NN	I-NP	O
:	:	:	O	O
Wife	Wife	NNP	B-NP	O
Feyler	Feyler	NNP	I-NP	O
856-867-5869	856-867-5869	CD	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
HCP	HCP	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Daughter	Daughter	NNP	B-NP	O
Hanus	Hanus	NNP	I-NP	O
349-806-0169	349-806-0169	CD	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
*	*	SYM	O	B-DNA
If	If	IN	B-SBAR	I-DNA
you	you	PRP	B-NP	O
develop	develop	VBP	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
,	,	,	O	O
fatigue	fatigue	NN	B-NP	O
,	,	,	O	O
palpitation	palpitation	NN	B-NP	O
,	,	,	O	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
you	you	PRP	B-NP	O
should	should	MD	B-VP	O
seek	seek	VB	I-VP	O
medical	medical	JJ	B-NP	O
help	help	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	B-protein
If	If	IN	B-SBAR	I-protein
you	you	PRP	B-NP	I-protein
SBP	SBP	NN	I-NP	I-protein
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
180	180	CD	B-NP	O
,	,	,	O	O
recheck	recheck	VB	B-VP	O
your	your	PRP$	B-NP	O
pressure	pressure	NN	I-NP	O
in	in	IN	B-PP	O
30	30	CD	B-NP	O
minutes	minute	NNS	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
it	it	PRP	B-NP	O
is	be	VBZ	B-VP	O
still	still	RB	I-VP	O
elevated	elevate	VBN	I-VP	O
.	.	.	O	O

Call	Call	VB	B-VP	O
your	your	PRP$	B-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

*	*	SYM	O	O
We	We	PRP	B-NP	O
changed	change	VBD	B-VP	O
your	your	PRP$	B-NP	O
toprol	toprol	NN	I-NP	O
25	25	CD	I-NP	O
to	to	TO	B-PP	O
lopressor	lopressor	NN	B-NP	O
25mg	25mg	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
*	*	SYM	O	O
We	We	PRP	B-NP	O
changed	change	VBD	B-VP	O
your	your	PRP$	B-NP	O
hydralazine	hydralazine	NN	I-NP	O
50mg	50mg	CD	B-NP	O
to	to	TO	I-NP	O
25mg	25mg	CD	I-NP	O
BID	BID	NN	I-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
*	*	SYM	O	O
It	It	PRP	B-NP	O
is	be	VBZ	B-VP	O
important	important	JJ	B-ADJP	O
that	that	IN	B-SBAR	O
you	you	PRP	B-NP	O
follow	follow	VBP	B-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Wirkkala	Wirkkala	NNP	I-NP	O
regarding	regard	VBG	B-PP	O
your	your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
they	they	PRP	B-NP	O
may	may	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
changed	change	VBN	I-VP	O
further	further	RBR	B-ADVP	O
once	once	IN	B-SBAR	O
you	you	PRP	B-NP	O
leave	leave	VBP	B-VP	O
the	the	DT	B-NP	O
hospital	hospital	NN	I-NP	O
*	*	SYM	B-VP	O
Your	Your	PRP$	B-NP	O
ativan	ativan	NN	I-NP	O
dose	dose	NN	I-NP	O
was	be	VBD	B-VP	O
changed	change	VBN	I-VP	O
to	to	TO	B-PP	O
1mg	1mg	NN	B-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
twice	twice	RB	B-NP	O
a	a	DT	I-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Please	Please	NN	B-NP	O
talk	talk	NN	I-NP	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Nagelkirk	Nagelkirk	NNP	I-NP	O
about	about	IN	B-PP	O
being	be	VBG	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
a	a	DT	B-NP	O
psychologist/psychiatrist	psychologist/psychiatrist	NN	I-NP	O
for	for	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
*	*	SYM	B-NP	O
You	You	PRP	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
your	your	PRP$	B-NP	O
coumadin	coumadin	NN	I-NP	O
level	level	NN	I-NP	O
checked	check	VBD	B-VP	O
on	on	IN	B-PP	O
3/17	3/17	CD	B-NP	O
and	and	CC	O	O
adjusted	adjust	VBN	B-VP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
MH	MH	NN	I-NP	O
coumadin	coumadin	NN	I-NP	O
clinic	clinic	NN	I-NP	O
FOR	FOR	NN	I-NP	O
VNA	VNA	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
draw	draw	NN	I-NP	O
INR	INR	NN	I-NP	O
on	on	IN	B-PP	O
3/17	3/17	CD	B-NP	O
.	.	.	O	O

Goal	Goal	NNP	B-NP	O
INR	INR	NNP	I-NP	O
2-3	2-3	NN	I-NP	O
-	-	HYPH	O	O
monitor	monitor	NN	B-NP	B-protein
BP	BP	NN	I-NP	I-protein
-	-	HYPH	B-NP	O
monitor	monitor	NN	I-NP	O
for	for	IN	B-PP	O
sob	sob	NN	B-NP	B-protein
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
-	-	HYPH	I-NP	O
monitor	monitor	NN	I-NP	O
daily	daily	JJ	I-NP	O
weights	weight	NNS	I-NP	O
-LRB-	-LRB-	TO	B-PP	O
dc	dc	NN	B-NP	O
weight	weight	NN	I-NP	O
74.9	74.9	CD	I-NP	O
kg	kg	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
f/u	f/u	NN	I-NP	O
INR	INR	NN	I-NP	O
and	and	CC	O	O
re-start/adjust	re-start/adjust	JJ	B-NP	O
coumadin	coumadin	NN	I-NP	O
as	as	IN	B-PP	O
needed	need	VBN	B-NP	O
-	-	HYPH	I-NP	O
check	check	NN	I-NP	B-protein
Cr	Cr	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
was	be	VBD	B-VP	O
slightly	slightly	RB	B-ADVP	O
above	above	IN	B-PP	O
baseline	baseline	NN	B-NP	O
CRI	CRI	NN	I-NP	O
Cr	Cr	NN	I-NP	O
level	level	NN	I-NP	O
in	in	IN	B-PP	O
house	house	NN	B-NP	B-protein
-RRB-	-RRB-	SYM	O	I-protein
-	-	HYPH	O	O
adjust	adjust	JJ	B-NP	O
bp	bp	NN	I-NP	O
meds	med	NNS	I-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
MAITA	MAITA	NNP	B-NP	O
,	,	,	O	O
LEMUEL	LEMUEL	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
PS40	PS40	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
11/19/07	11/19/07	CD	I-NP	O
@	@	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

